Leaderboard

En | De
Sie sind hier: Gastroenterologie » Leber » Neoplasie 21. Januar 2025
Suchen
medline.ch
Neoplasie
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gallenwege
Leber
Hepatitis
Leberzirrhose
Neoplasie
Portale Hypertonie
Anderes
Magen-Darm
Oesophagus
Pankreas
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 3528  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 70545  
   
Role of immune cell homeostasis in research and treatment response in hepatocellular carcinoma.
Clin Exp Med
Song W, Li M, Liu W, Xu W, Zhou H, Wei S, Chi J.
PMID: 39826024 [PubMed - indexed for MEDLINE]


Safety and efficacy of PD-1 inhibitor (sintilimab) combined with transarterial chemoembolization as the initial treatment in patients with intermediate-stage hepatocellular carcinoma beyond up-to-seven criteria.
J Immunother Cancer
Li L, Xu X, Wang W, Huang P, Yu L, Ren Z, Fan J, Zhou J, Zhang L, Wang Z.
PMID: 39824532 [PubMed - indexed for MEDLINE]


Retrospective evaluation of a novel ultrasound-based imaging analysis software for predicting radiofrequency ablation areas.
PLoS One
Sato M, Tateishi R, Zohar Y, Sato J, Watadani T, Moriyama M, Wake T, Nakagomi R, Kinoshita MN, Nakatsuka T, Minami T, Uchino K, Enooku K, Nakagawa H, Asaoka Y, Yamada R, Even N, Amitai I, Abu Y, Fujishiro M, Koike K.
PMID: 39823502 [PubMed - indexed for MEDLINE]


An Overview of In Vitro Models of Alcohol-Related Hepatocellular Carcinoma.
Cancer Med
Courtois A, Gérard S, Esparteiro D, Nguyen-Khac E, Marcq I, Fouquet G.
PMID: 39823133 [PubMed - indexed for MEDLINE]


DAA-PASS: A Prospective Evaluation of HCC Recurrence After Direct Acting Antiviral Therapy.
J Viral Hepat
Singal AG, Reddy KR, Colombo M, Morris HL, Mospan AR, Cabrera R, Kelley RK, Kilpatrick RD, Trevisani F, Farinati F, Giannini EG, Mehta N, Fried MW, Sangro B, DAA.
PMID: 39822115 [PubMed - indexed for MEDLINE]


Exploring early postoperative core symptoms in Chinese patients with primary liver cancer: a cross-sectional and longitudinal network analysis.
Support Care Cancer
Zhang H, Li S, Yuan M, Liu J, Fan H, Li S.
PMID: 39820759 [PubMed - indexed for MEDLINE]


Predictors for 30-day mortality in hepatocellular carcinoma patients undergoing liver resection.
Narra J
Prabowo E, Susilaningsih N, Suharti C, Purnomo HD, Riwanto I, Fuadi AF, Ar A, Bulandari B, Tjandra KC, Respati DR, Rampengan DD.
PMID: 39816077 [PubMed - indexed for MEDLINE]


Integrating single-cell RNA-Seq and bulk RNA-Seq data to explore the key role of fatty acid metabolism in hepatocellular carcinoma.
Sci Rep
Dai H, Tao X, Shu Y, Liu F, Cheng X, Li X, Shu B, Luo H, Chen X, Cheng Z.
PMID: 39814999 [PubMed - indexed for MEDLINE]


Environmental exposures and the risk of hepatocellular carcinoma.
Hepatol Commun
Rayapati D, McGlynn KA, Groopman JD, Kim AK.
PMID: 39813595 [PubMed - indexed for MEDLINE]


Imaging characteristics of hypervascular focal nodular hyperplasia-like lesions in patients with chronic alcoholic liver disease.
World J Gastroenterol
Urase A, Tsurusaki M, Kozuki R, Kono A, Sofue K, Ishii K.
PMID: 39811504 [PubMed - indexed for MEDLINE]


Trends of alkaline phosphatase to prealbumin ratio in patients with hepatitis B linked to hepatocellular carcinoma development.
World J Gastroenterol
Zhen WC, Sun J, Bai XT, Zhang Q, Li ZH, Zhang YX, Xu RX, Wu W, Yao ZH, Pu CW, Li XF.
PMID: 39811503 [PubMed - indexed for MEDLINE]


The impact of metabolic syndrome on hepatocellular carcinoma: a mendelian randomization study.
Sci Rep
Yuan C, Shu X, Wang X, Chen W, Li X, Pei W, Su X, Hu Z, Jie Z.
PMID: 39809981 [PubMed - indexed for MEDLINE]


Photon-Counting CT Effects on Sensitivity for Liver Lesion Detection: A Reader Study Using Virtual Imaging.
Radiology
Wildman-Tobriner B, Felice N, Kalisz KR, Allen BC, Thomas SP, Kruse DE, Segars WP, Harrawood B, Bashir MR, Marin D, Morrison S, Erkanli A, Samei E, Abadi E.
PMID: 39807984 [PubMed - indexed for MEDLINE]


Expert consensus on sequential surgery after immune-targeted conversion therapy for advanced hepatocellular carcinoma in China.
Biosci Trends
Song P, Tang W, Kokudo N.
PMID: 39805614 [PubMed - indexed for MEDLINE]


Impact of depth of body cavity at the upper-right portion of the abdomen on open and laparoscopic liver resection of segment 7.
Langenbecks Arch Surg
Gon H, Komatsu S, Soyama H, Tanaka M, Kido M, Fukushima K, Urade T, So S, Yoshida T, Arai K, Tsugawa D, Yanagimoto H, Toyama H, Fukumoto T.
PMID: 39804508 [PubMed - indexed for MEDLINE]


Nomogram for predicting early cancer-related death due to recurrence after liver resection in hepatocellular carcinoma patients with Barcelona Clinic Liver Cancer (BCLC) stage B/C: a multicenter study.
BMC Gastroenterol
Qiu ZC, Cai HZ, Wu YW, Dai JL, Qi WL, Chen CW, Xu YQ, Li C, Wen TF.
PMID: 39800706 [PubMed - indexed for MEDLINE]


Impact of postoperative morbidity on the prognosis of patients with hepatocellular carcinoma after laparoscopic liver resection: a multicenter observational study.
Sci Rep
Yang S, Ni H, Zhang A, Zhang J, Zang H, Ming Z.
PMID: 39799160 [PubMed - indexed for MEDLINE]


Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study.
Lancet
Sangro B, Kudo M, Erinjeri JP, Qin S, Ren Z, Chan SL, Arai Y, Heo J, Mai A, Escobar J, Lopez Chuken YA, Yoon JH, Tak WY, Breder VV, Suttichaimongkol T, Bouattour M, Lin SM, Peron JM, Nguyen QT, Yan L, Chiu CF, Santos FA, Veluvolu A, Thungappa SC, Matos M, , Udoye SI, Kurland JF, Cohen GJ, Lencioni R, EMERALD-1 Investigators.
PMID: 39798579 [PubMed - indexed for MEDLINE]


Transarterial chemoembolisation combined with lenvatinib plus pembrolizumab versus dual placebo for unresectable, non-metastatic hepatocellular carcinoma (LEAP-012): a multicentre, randomised, double-blind, phase 3 study.
Lancet
Kudo M, Ren Z, Guo Y, Han G, Lin H, Zheng J, Ogasawara S, Kim JH, Zhao H, Li C, Madoff DC, Ghobrial RM, Kawaoka T, Gerolami R, Ikeda M, Kumada H, El-Khoueiry AB, Vogel A, Peng X, Mody K, Dutcus C, Dubrovsky L, Siegel AB, Finn RS, Llovet JM, LEAP-012 investigators.
PMID: 39798578 [PubMed - indexed for MEDLINE]


NAFLD and NAFLD Related HCC: Emerging Treatments and Clinical Trials.
Int J Mol Sci
Khare T, Liu K, Chilambe LO, Khare S.
PMID: 39796162 [PubMed - indexed for MEDLINE]


   
   Artikel 1 - 20 / 70545    Seite 1 von 3528  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Benutzername

Passwort

 

 

Haben Sie Ihr Passwort vergessen?

 

Neu bei My Medline?

Melden Sie sich bei My Medline an!

 

Mehr über My Medline erfahren

mehr >>

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1